title: The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study.
authors.affiliation: Department of Neurology, VU Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands j.vanrossum@vumc.nl.
authors.forename: Johannis A
authors.initials: JA
authors.lastname: van Rossum
authors.affiliation: VU Medical Centre, Amsterdam, The Netherlands.
authors.forename: Anke
authors.initials: A
authors.lastname: Vennegoor
authors.affiliation: VU Medical Centre, Amsterdam, The Netherlands.
authors.forename: Joep
authors.initials: J
authors.lastname: Killestein
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001007:Anxiety; D005260:Female; D006801:Humans; D007577:JC Virus; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000523:psychology* / Q000821:virology*; D027601:Polyomavirus Infections / Q000150:complications*
chemical_list: D061067:Antibodies, Monoclonal, Humanized